Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Satralizumab treatment in adults with aquaporin-4 immunoglobulin G-seropositive neuromyelitis optica spectrum disorder in clinical practice.
Journal: Multiple sclerosis journal - experimental, translational and clinical
Published: May 29, 2025
Immune response to influenza vaccine in patients with relapsing multiple sclerosis treated with ofatumumab: Results from an open-label, multicenter, phase 4 study.
Journal: Multiple sclerosis and related disorders
Published: July 09, 2024
Satralizumab treatment in patients with AQP4-IgG-seropositive neuromyelitis optica spectrum disorder after rituximab treatment: A case series.
Journal: Journal of neuroimmunology
Published: June 21, 2024
Long-term efficacy and safety of alemtuzumab in patients with RRMS: 12-year follow-up of CAMMS223.
Journal: Journal of neurology
Published: March 06, 2020
Efficacy of alemtuzumab over 6 years in relapsing-remitting multiple sclerosis patients who relapsed between courses 1 and 2: Post hoc analysis of the CARE-MS studies.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: November 02, 2019
Efficacy and Safety of Alemtuzumab in Patients of African Descent with Relapsing-Remitting Multiple Sclerosis: 8-Year Follow-up of CARE-MS I and II (TOPAZ Study).
Journal: Neurology and therapy
Published: July 03, 2019
Immune thrombocytopenia in alemtuzumab-treated MS patients: Incidence, detection, and management.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: February 21, 2019
CLIPPERS complicating multiple sclerosis causing concerns of CNS lymphoma.
Journal: Neurology
Published: August 03, 2012
Showing 1-9 of 9
Last Updated: 09/26/2026